Diabetes-Related Effectiveness and Cost of Liraglutide or Insulin in German Patients With Type 2 Diabetes: A 5-year Retrospective Claims Analysis

figure

posted on 2020-08-19, 08:46 authored by Thomas Wilke, Sabrina Mueller, Andreas Fuchs, Margit S. Kaltoft, Stefan Kipper, Malgorzata Cel

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

Usage metrics

Keywords

Claims data Cost; Effectiveness Germany Insulin Propensity score Real-world Type 2 diabetes

Licence

CC BY-NC 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM